Works matching IS 10781552 AND DT 2021 AND VI 27 AND IP 4
Results: 45
Clinical controversies in the treatment of cancer-associated venous thromboembolism.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 939, doi. 10.1177/1078155220984371
- By:
- Publication type:
- Article
Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 954, doi. 10.1177/1078155220984846
- By:
- Publication type:
- Article
A novel agnostic tumor: NTRKoma.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 907, doi. 10.1177/1078155220967738
- By:
- Publication type:
- Article
Cost analysis of daratumumab therapy: Is there a cost benefit to using the recently approved subcutaneous product versus the IV product?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 978, doi. 10.1177/1078155221993218
- By:
- Publication type:
- Article
International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 785, doi. 10.1177/10781552211017199
- By:
- Publication type:
- Article
Dose-escalation strategy in refractory metastatic colorectal cancer: A change in terms of cost-effectiveness.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 974, doi. 10.1177/1078155221992546
- By:
- Publication type:
- Article
Corrigendum to Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.
- Published in:
- 2021
- Publication type:
- Correction Notice
How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 919, doi. 10.1177/10781552211009291
- By:
- Publication type:
- Article
Comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Response to comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 911, doi. 10.1177/10781552211004705
- By:
- Publication type:
- Article
Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Ambulatory chemotherapy: Past, present, and future.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 962, doi. 10.1177/1078155220985916
- By:
- Publication type:
- Article
A case of successful acyclovir desensitization in a bone marrow transplant patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1033, doi. 10.1177/1078155220959408
- By:
- Publication type:
- Article
Case report on 5-fluorouracil induced cerebrovascular accident.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1016, doi. 10.1177/1078155220954900
- By:
- Publication type:
- Article
Acute pancreatitis in a patient treated with imatinib and gefitinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 980, doi. 10.1177/1078155220949639
- By:
- Publication type:
- Article
Unleashing the power of immunotherapy and targeted therapy combinations: Advancing cancer care or discovering unknown toxicities?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 930, doi. 10.1177/1078155220984235
- By:
- Publication type:
- Article
Interstitial nephritis with pembrolizumab: A case report and review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1046, doi. 10.1177/1078155220961553
- By:
- Publication type:
- Article
Central diabetes insipidus induced by temozolomide: A report of two cases.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1040, doi. 10.1177/1078155220961551
- By:
- Publication type:
- Article
Lorlatinib induced proteinuria: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1037, doi. 10.1177/1078155220961549
- By:
- Publication type:
- Article
Impact of clinical pharmacists in an inpatient medical oncology service: A prospective study at a comprehensive cancer center in Jordan.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 897, doi. 10.1177/1078155220943277
- By:
- Publication type:
- Article
Exemestane induced cholestatic liver injury – A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1029, doi. 10.1177/1078155220957726
- By:
- Publication type:
- Article
Atezolizumab-induced hemolytic anemia – A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1026, doi. 10.1177/1078155220957720
- By:
- Publication type:
- Article
Hypertriglyceridemia induced by S-1: A novel case report and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1020, doi. 10.1177/1078155220956691
- By:
- Publication type:
- Article
Efficacy of a conversion from filgrastim to filgrastim-sndz in stem cell transplant patients undergoing mobilization.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 871, doi. 10.1177/1078155220941582
- By:
- Publication type:
- Article
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1011, doi. 10.1177/1078155220953886
- By:
- Publication type:
- Article
Safe administration of chemotherapy in mast cell activation syndrome.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1005, doi. 10.1177/1078155220953879
- By:
- Publication type:
- Article
Significant interaction between high-dose methotrexate and high-dose piperacillin-tazobactam causing reversible neurotoxicity and renal failure in an osteosarcoma patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1000, doi. 10.1177/1078155220953878
- By:
- Publication type:
- Article
Alternative use of BRAF inhibitors in patients with metastatic melanoma unable to swallow pills.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 996, doi. 10.1177/1078155220953877
- By:
- Publication type:
- Article
Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 990, doi. 10.1177/1078155220951850
- By:
- Publication type:
- Article
68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 984, doi. 10.1177/1078155220951242
- By:
- Publication type:
- Article
Assessment of extended urine protein monitoring frequency in patients receiving bevacizumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 902, doi. 10.1177/1078155220943959
- By:
- Publication type:
- Article
Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 887, doi. 10.1177/1078155220941937
- By:
- Publication type:
- Article
Real-world data on patients with metastatic non-small-cell lung cancer treated with checkpoint inhibitors in an Italian Teaching Hospital in 2015–2018.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 877, doi. 10.1177/1078155220941586
- By:
- Publication type:
- Article
Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 857, doi. 10.1177/1078155220940416
- By:
- Publication type:
- Article
Risk reduction in a cancer chemotherapy production unit: Contribution of an automated drug dispensing system.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 863, doi. 10.1177/1078155220941060
- By:
- Publication type:
- Article
Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 847, doi. 10.1177/1078155220940410
- By:
- Publication type:
- Article
Glioblastoma and bevacizumab in elderly patients: Monocentric study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 842, doi. 10.1177/1078155220940396
- By:
- Publication type:
- Article
Use of active learning and simulation to teach pharmacy students order verification and patient education best practices with oral oncolytic therapies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 834, doi. 10.1177/1078155220940395
- By:
- Publication type:
- Article
Physical and chemical stability of cytarabine in polypropylene syringes.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 827, doi. 10.1177/1078155220937405
- By:
- Publication type:
- Article
Characterization of relapse patterns in patients with acute lymphoblastic leukemia treated with blinatumomab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 821, doi. 10.1177/1078155220934853
- By:
- Publication type:
- Article
Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology–oncology and transplant clinic: Assessment and significance.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 815, doi. 10.1177/1078155220934167
- By:
- Publication type:
- Article
Identification of target small molecule tyrosine kinase inhibitors that need monitoring and clinical application of protocol for early detection of cancer therapeutics-related cardiac dysfunction using signal detection: An investigation of real world data
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 804, doi. 10.1177/1078155220930367
- By:
- Publication type:
- Article